GSD NovaPrime® SARS-CoV-2 Direct RT-PCR (4x96 reactions)
The GSD NovaPrime® SARS-CoV-2 Direct RT-PCR is intended for the qualitative determination of SARS-CoV-2 genomic RNA from human nasopharyngeal dry swabs, eluted directly into deionized water without additional RNA extraction process.
More than ever, there is a critical need for rapid molecular solutions to improve testing capacity, and provide accurate and quicker results. Applications for an RT-PCR direct method are diverse, making a real impact in settings where recurrent, affordable, and faster testing is desirable, such as for healthcare personnel or essential workers.
Removing the RNA extraction step helps to:
- Simplify the process for COVID-19 testing
- Meet the increasing global demand for molecular solutions
- Maximize accessibility of RT-PCR testing to a larger number of laboratories
- Increase test processing
- Reduce the cost, labour, and time required to perform RT-PCR
GSD NovaPrime® SARS-CoV-2 Direct RT-PCR has been a validated method. This new workflow shortens the complete turnaround time of the test, providing results in less than 2 hours from sample to result without compromising the high accuracy of PCR testing.
|No. of tests||4 x 96|
|Time to Result||Less than 2 hours|
|PCR cycler platforms||AriaDxTM/ AriaMxTM (Agilent Technologies)|
|Kit components||RT-PCR Enzyme Mix, Primer-Probe-Mix, Lysis Control, Positive Control, Nuclease Free Water|